Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation.

Najimi M, Berardis S, El-Kehdy H, Rosseels V, Evraerts J, Lombard C, El Taghdouini A, Henriet P, van Grunsven L, Sokal EM.

Stem Cell Res Ther. 2017 Jun 5;8(1):131. doi: 10.1186/s13287-017-0575-5.


Adult-Derived Human Liver Stem/Progenitor Cells Infused 3 Days Postsurgery Improve Liver Regeneration in a Mouse Model of Extended Hepatectomy.

Herrero A, Prigent J, Lombard C, Rosseels V, Daujat-Chavanieu M, Breckpot K, Najimi M, Deblandre G, Sokal EM.

Cell Transplant. 2017 Feb 16;26(2):351-364. doi: 10.3727/096368916X692960. Epub 2016 Sep 21.


Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells.

Berardis S, Lombard C, Evraerts J, El Taghdouini A, Rosseels V, Sancho-Bru P, Lozano JJ, van Grunsven L, Sokal E, Najimi M.

PLoS One. 2014 Jan 21;9(1):e86137. doi: 10.1371/journal.pone.0086137. eCollection 2014.


Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules.

Hultberg A, Temperton NJ, Rosseels V, Koenders M, Gonzalez-Pajuelo M, Schepens B, Ibañez LI, Vanlandschoot P, Schillemans J, Saunders M, Weiss RA, Saelens X, Melero JA, Verrips CT, Van Gucht S, de Haard HJ.

PLoS One. 2011 Apr 1;6(4):e17665. doi: 10.1371/journal.pone.0017665.


A non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus.

Rosseels V, Nazé F, De Craeye S, Francart A, Kalai M, Van Gucht S.

J Virol Methods. 2011 Apr;173(1):127-36. doi: 10.1016/j.jviromet.2011.01.019. Epub 2011 Feb 3.


Development and validation of a triplex real-time PCR for rapid detection and specific identification of M. avium sub sp. paratuberculosis in faecal samples.

Irenge LM, Walravens K, Govaerts M, Godfroid J, Rosseels V, Huygen K, Gala JL.

Vet Microbiol. 2009 Apr 14;136(1-2):166-72. doi: 10.1016/j.vetmic.2008.09.087. Epub 2008 Oct 21.


Vaccination against paratuberculosis.

Rosseels V, Huygen K.

Expert Rev Vaccines. 2008 Aug;7(6):817-32. doi: 10.1586/14760584.7.6.817. Review.


Immunogenicity and protective efficacy of DNA vaccines encoding MAP0586c and MAP4308c of Mycobacterium avium subsp. paratuberculosis secretome.

Roupie V, Leroy B, Rosseels V, Piersoel V, Noël-Georis I, Romano M, Govaerts M, Letesson JJ, Wattiez R, Huygen K.

Vaccine. 2008 Sep 2;26(37):4783-94. doi: 10.1016/j.vaccine.2008.07.009. Epub 2008 Jul 22.


Genetic resistance of mice to Mycobacterium paratuberculosis is influenced by Slc11a1 at the early but not at the late stage of infection.

Roupie V, Rosseels V, Piersoel V, Zinniel DK, Barletta RG, Huygen K.

Infect Immun. 2008 May;76(5):2099-105. doi: 10.1128/IAI.01137-07. Epub 2008 Feb 19.


Antigen discovery: a postgenomic approach to paratuberculosis diagnosis.

Leroy B, Roupie V, Noël-Georis I, Rosseels V, Walravens K, Govaerts M, Huygen K, Wattiez R.

Proteomics. 2007 Apr;7(7):1164-76.


Development of luminescent Mycobacterium avium subsp. paratuberculosis for rapid screening of vaccine candidates in mice.

Rosseels V, Roupie V, Zinniel D, Barletta RG, Huygen K.

Infect Immun. 2006 Jun;74(6):3684-6.


Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.

D'Souza S, Rosseels V, Romano M, Tanghe A, Denis O, Jurion F, Castiglione N, Vanonckelen A, Palfliet K, Huygen K.

Infect Immun. 2003 Jan;71(1):483-93.


IFN-gamma diagnostic tests in the context of bovine mycobacterial infections in Belgium.

Walravens K, Marché S, Rosseels V, Wellemans V, Boelaert F, Huygen K, Godfroid J.

Vet Immunol Immunopathol. 2002 Sep 10;87(3-4):401-6.


Improved tuberculosis DNA vaccines by formulation in cationic lipids.

D'Souza S, Rosseels V, Denis O, Tanghe A, De Smet N, Jurion F, Palfliet K, Castiglioni N, Vanonckelen A, Wheeler C, Huygen K.

Infect Immun. 2002 Jul;70(7):3681-8.


Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.

Tanghe A, D'Souza S, Rosseels V, Denis O, Ottenhoff TH, Dalemans W, Wheeler C, Huygen K.

Infect Immun. 2001 May;69(5):3041-7.

Supplemental Content

Loading ...
Support Center